| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/30/1993 | WO1993019165A1 Colon crypt cell mitogen, cell line producing it, and uses thereof |
| 09/30/1993 | WO1993018793A1 Preparation and use of polyanionic polymer-based conjugates targeted to vascular endothelial cells |
| 09/30/1993 | WO1993018785A1 Novel medicament |
| 09/30/1993 | WO1993018759A1 A dna transporter system and method of use |
| 09/30/1993 | WO1993018755A1 Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
| 09/30/1993 | WO1993018754A1 Self-assembling diketopiperazine drug delivery system |
| 09/30/1993 | WO1993018752A1 Topical and transdermal delivery system utilizing submicron oil spheres |
| 09/30/1993 | WO1993018750A1 Method for reducing side-effects of a drug |
| 09/30/1993 | WO1993018746A1 Pressurized gas packagings using polyoxyethylene glyceryl-obates |
| 09/30/1993 | WO1993012814A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 09/30/1993 | DE4309168A1 Powdery starting materials for coating solns. for pharmaceuticals - contain hydroxy propyl-methyl-cellulose or methyl cellulose of a specific particle size range |
| 09/30/1993 | CA2590810A1 Topical and transdermal delivery system utilizing submicron oil spheres |
| 09/30/1993 | CA2132095A1 Colon crypt cell mitogen, cell line producing it, and uses thereof |
| 09/30/1993 | CA2131620A1 A dna transporter system and method of use |
| 09/29/1993 | EP0563024A1 Percutaneous salve preparation in the form of an adhesive tape |
| 09/29/1993 | EP0563013A2 N-substituted chitosane derivatives, process for preparing them and their use |
| 09/29/1993 | EP0562863A1 Protein stabilised oil-in-water emulsions |
| 09/29/1993 | EP0562641A1 Dehydrated liposomes |
| 09/29/1993 | EP0562637A1 Opacifier for water-based compositions |
| 09/29/1993 | EP0562445A2 Ophthalmic gel |
| 09/29/1993 | EP0561983A1 Systems for administering drugs transdermally using sorbitan esters as skin permeation enhancers |
| 09/29/1993 | EP0561874A1 Non-aqueous microemulsion for drug delivery |
| 09/29/1993 | EP0553195A4 Biocompatible microcapsules |
| 09/29/1993 | EP0523150A4 Device and method for enhanced administration of physostigmine |
| 09/29/1993 | EP0428520B1 Antimicrobial composition with long-term activity |
| 09/29/1993 | EP0382781B1 Composition for treating cancers characterized by over-expression of the c-fms proto-oncogene |
| 09/28/1993 | US5248772 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 09/28/1993 | US5248674 Percutaneous administration of 3'-azide'-deoxythymidine |
| 09/28/1993 | US5248501 Plant extract for reducing irritation, dryness |
| 09/28/1993 | US5248494 Applying in a carrier to skins |
| 09/28/1993 | CA2092513A1 N-substituted chitosan derivatives, process for their preparation and the use thereof |
| 09/23/1993 | DE4230876A1 Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten Aerosols under-use of polyoxyethylene glyceryl oleates |
| 09/23/1993 | DE4208527A1 Liposomen mit negativer ueberschussladung Liposomes with negative excess charge |
| 09/23/1993 | DE4207922A1 New water-soluble inclusion complexes contg randomly substd. methyl-beta-cyclodextrin - for admin. of substances which are only sparingly soluble in water |
| 09/22/1993 | EP0561523A2 Sugar compound, sialic acid-containing sugar chains' biosynthesis inhibitor, production process thereof and intermediate |
| 09/22/1993 | EP0561424A1 Dehydrated liposomes |
| 09/22/1993 | EP0561330A1 Topical insulin preparation |
| 09/22/1993 | EP0561152A1 Coating compositions, its use as clear coatings and process for the preparation of multilayered coatings |
| 09/22/1993 | EP0561119A1 Material of animal origin for use in surgery |
| 09/22/1993 | EP0560937A1 Pharmaceutical compositions |
| 09/22/1993 | EP0560821A1 Solid dosage forms of almokalant and processes for manufacture thereof |
| 09/22/1993 | EP0560816A1 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof |
| 09/22/1993 | EP0526578A4 Composition and method for topical treatment of damaged or diseased tissue |
| 09/22/1993 | EP0479781B1 Pharmaceutical composition containing a hydrophilic active compound treated by an organic acid and encapsulated in a liposome |
| 09/22/1993 | EP0258356B1 New pharmaceutical compositions for inhalation |
| 09/22/1993 | CN1076358A Methods and compositions for reducing multi-drug resistance |
| 09/21/1993 | US5247121 Cosmetics |
| 09/21/1993 | US5247075 Tri-aza macrocycles and metal complexes thereof |
| 09/21/1993 | US5247069 Ligands and methods for augmenting B-cell proliferation |
| 09/21/1993 | US5246949 Preparation for endermism containing dopamine derivatives |
| 09/21/1993 | US5246704 Vaginal suppository |
| 09/21/1993 | US5246702 Process for the purification of commercial carrageenins |
| 09/21/1993 | US5246698 Hylans and derivatives, polysaccharides, proteins, polyvinylpyrrolidone and polyoxyethylene glycol |
| 09/21/1993 | US5246697 Kanamycin A with vehicle or support |
| 09/21/1993 | CA1322341C Method for the preparation of antibody-fragment conjugates |
| 09/21/1993 | CA1322332C Protein c inhibitor (pci) as pharmaceutical and diagnostic aid a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci |
| 09/21/1993 | CA1322328C Stabilized compositions containing epidermal growth factor |
| 09/16/1993 | WO1993018180A1 Method for enzymatically synthesizing peptide alkyl esters, resulting products and use thereof |
| 09/16/1993 | WO1993018162A1 Pathogen-targeted biocatalyst |
| 09/16/1993 | WO1993017784A1 Polysaccharide wall microcapsules containing primary alcohol functions and compositions containig same |
| 09/16/1993 | WO1993017718A1 Improvements in or relating to contrast agents |
| 09/16/1993 | WO1993017716A1 Compositions for controlled delivery of pharmaceutical compounds |
| 09/16/1993 | WO1993017715A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
| 09/16/1993 | WO1993017714A1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy |
| 09/16/1993 | WO1993017713A1 Pharmaceutical composition having site-specific delivery |
| 09/16/1993 | WO1993017712A2 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 09/16/1993 | WO1993017711A1 New cyclodextrins and new formulated drugs |
| 09/16/1993 | WO1993017710A1 Pharmaceutical preparation for percutaneous administration |
| 09/16/1993 | WO1993017707A1 In vivo binding pair pretargeting |
| 09/16/1993 | WO1993017699A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | WO1993017693A1 Albumin-iodine preservation of blood, tissues and biological fluids |
| 09/16/1993 | WO1993017687A1 Topical compositions containing steroids |
| 09/16/1993 | WO1993017679A1 Compositions containing ranitidine/bismuth carboxylates salts |
| 09/16/1993 | WO1993017675A1 Use of alkylureas and hydroxyurea as contraceptive agents |
| 09/16/1993 | WO1993017674A1 Topical use of local anaesthetic agents for rheumatoid arthritis as well as a pharmaceutical preparation and a method for the treatment thereof |
| 09/16/1993 | WO1993017670A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 09/16/1993 | WO1993017669A1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 09/16/1993 | WO1993017668A1 Controlled release acth containing microspheres |
| 09/16/1993 | WO1993017667A1 Composition for oral preparations |
| 09/16/1993 | WO1993017663A1 Pharmaceutical inhalation compositions |
| 09/16/1993 | WO1993017655A1 Topical aromatic releasing compositions |
| 09/16/1993 | CA2452130A1 Methods and compositions for targeting the vasculature of solid tumors |
| 09/16/1993 | CA2131990A1 Pharmaceutical composition having site-specific delivery |
| 09/16/1993 | CA2131832A1 Compositions for controlled delivery of pharmaceutical compounds |
| 09/16/1993 | CA2131801A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 09/16/1993 | CA2131637A1 Process for enzyme synthesis of alkyl esters of peptides, products thus obtained and use of the said products |
| 09/16/1993 | CA2131530A1 Polysaccharide wall microcapsules containing primary alcohol functions and compositions containing same |
| 09/16/1993 | CA2131382A1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy |
| 09/16/1993 | CA2131299A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | CA2129514A1 Controlled released acth containing microspheres |
| 09/15/1993 | EP0560409A2 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 09/15/1993 | EP0560329A1 Pranoprofen-containing, suspending medicinal composition |
| 09/15/1993 | EP0560207A1 Composition based on ibuprofen, for oral usage |
| 09/15/1993 | EP0559856A1 Antimicrobial preservation of platelets and blood factors |
| 09/15/1993 | EP0559812A1 Composition containing antihistamine h 2? receptor antagonists and bioadhesive material |
| 09/15/1993 | EP0559738A1 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
| 09/15/1993 | EP0559698A1 Methods of immobilizing liposomes in gel beads and similar materials, gel beads and similar materials with immobilized liposomes prepared by such methods and uses thereof |
| 09/15/1993 | EP0559645A1 Composition for solid pharmaceutical preparations containing active vitamins d 3? and process for preparation thereof |
| 09/15/1993 | EP0544671A4 Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting ph-dependent swelling |
| 09/15/1993 | EP0527735A4 Cholesterol removal |